Rocket Pharmaceuticals, Inc. Government Contract Receivable, Progress Payment Offset
Rocket Pharmaceuticals, Inc. (RCKT) had Government Contract Receivable, Progress Payment Offset of $0 as of 2020-03-31, per its 10-Q filed 2020-05-08.
Discontinued › Notes
us-gaap:GovernmentContractReceivableProgessPaymentsOffset · last filed 2020-05-08
- 2020-03-31: Government Contract Receivable, Progress Payment Offset $0.00.
- 2019-12-31: Government Contract Receivable, Progress Payment Offset $1.20M.
- 2019-09-30: Government Contract Receivable, Progress Payment Offset $400.00K.
- 2019-06-30: Government Contract Receivable, Progress Payment Offset $1.10M; Government Contract Receivable, Progress Payment Offset as first filed $800.00K.
| Period end | Government Contract Receivable, Progress Payment Offset | Government Contract Receivable, Progress Payment Offset as first filed |
|---|---|---|
| 2020-03-31 | $0.00 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $1.20M 10-Q · filed 2020-05-08 | |
| 2019-09-30 | $400.00K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $1.10M 10-Q · filed 2019-11-08 | $800.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $800.00K 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |